Ju Dong Yang, W. Ray Kim, Kyung Woo Park, Roongruedee Chaiteerakij, Bohyun Kim, Schuyler O. Sanderson, Joseph J. Larson, Rachel A. Pedersen, Terry M. Therneau, Gregory J. Gores, Lewis R. Roberts, Joong‐Won Park – 28 February 2012 – Survival of patients with hepatocellular carcinoma (HCC) is determined by the extent of the tumor and the underlying liver function. We aimed to develop a survival model for HCC based on objective parameters including the Model for Endstage Liver Disease (MELD) as a gauge of liver dysfunction.

Mi‐Suk Park, Sooah Kim, Jignesh Patel, Cristina H. Hajdu, Richard K. G. Do, Lorenzo Mannelli, James S. Babb, Bachir Taouli – 28 February 2012 – This study evaluates the performance of diffusion‐weighted magnetic resonance imaging (DWI) for the detection of hepatocellular carcinoma (HCC) in pre–liver transplantation patients, compared and combined with contrast‐enhanced T1‐weighted imaging (CET1WI), using liver explant as the standard of reference.

Praveen Sharma, Anil Arora – 28 February 2012

Shujuan Chen, Mei‐Fei Yueh, Ronald M. Evans, Robert H. Tukey – 28 February 2012 – In humanized UDP glucuronosyltransferase‐1 (hUGT1) mice that express the entire UGT1 locus, the maternal hepatic UGT1A genes are dramatically induced 12‐14 days after conception. Steroid induction of the UGT1A1 gene indicates that xenobiotic sensors, such as the pregnane X receptor (PXR) and constitutive androstane receptor (CAR), may underlie the induction process. In contrast, neonatal hUGT1 mice display severe hyperbilirubinemia, with limited expression of the UGT1A genes.

Jessy Cattelan, Evelyne Racadot, Vincent Di Martino, Thierry Thevenot – 28 February 2012

Umid M. Sharapov, Lisa R. Bulkow, Susan E. Negus, Philip R. Spradling, Chriss Homan, Jan Drobeniuc, Michael Bruce, Saleem Kamili, Dale J. Hu, Brian J. McMahon – 28 February 2012 – Persistence of seropositivity conferred by hepatitis A vaccine administered to children <2 years of age is unknown and passively transferred maternal antibodies to hepatitis A virus (maternal anti‐HAV) may lower the infant's immune response to the vaccine.

Robert P. Myers – 28 February 2012

Heather Francis – 28 February 2012

Gong‐Hao He, Gui‐Li Xu, Wen‐Ke Cai, Wei Xia – 28 February 2012

Ian A. Rowe, Richard Parker, Matthew J. Armstrong, Diarmaid D. Houlihan, David J. Mutimer – 28 February 2012 – Hepatitis A virus (HAV) superinfection in persons with hepatitis C virus (HCV) infection has been associated with a high mortality rate, and vaccination is recommended. The incidence of HAV is low, and the aim of this study was to determine the mortality risk of HAV superinfection and the consequences of routine vaccination in persons with HCV infection.